Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
Journal of Clinical Medicine|February 10, 2024
Platelets and Thrombotic Antiphospholipid SyndromeIbrahim Tohidi-Esfahani, Prabal Mittal, David Isenberg, et al.
Journal of Clinical Medicine|January 11, 2022
Comparison of Acquired Activated Protein C Resistance, Using the CAT and ST-Genesia<sup>®</sup> Analysers and Three Thrombin Generation Methods, in APS and SLE PatientsMaria Efthymiou, Philip J Lane, David Isenberg, et al.
Rheumatology (Oxford, England)|June 6, 2015
Longer duration of B cell depletion is associated with better outcomeSofia Sapeta Dias, Veronica Rodriguez-Garcia, Hanh Nguyen, et al.
Autoimmunity Reviews|September 1, 2009
Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritisThomas Dörner, David Isenberg, David Jayne, et al.
The Lancet. Haematology|August 1, 2020
Management of anticoagulant-refractory thrombotic antiphospholipid syndromeHannah Cohen, Zara Sayar, Maria Efthymiou, et al.
Rheumatology (Oxford, England)|April 22, 2022
Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+ year periodGoncalo Durao-Carvalho, Raquel Fernández-González, Bethan Goulden, et al.
Arthritis Care & Research|November 12, 2015
Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year PeriodCarmen V Medina-Quiñones, Lucía Ramos-Merino, Pablo Ruiz-Sada, et al.
Expert Opinion on Biological Therapy|April 7, 2026
The role of monoclonal antibodies in the treatment of lupus nephritisUxía Couto-Lareo, Blanca Viejo-Sosa, Mònica Angerri-Nadal, et al.
Annals of the Rheumatic Diseases|June 22, 2014
Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)David Isenberg, Caroline Gordon, Daiana Licu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2016
Post Hoc Analysis of the Phase II/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRILCaroline Gordon, David Wofsy, Stephen Wax, et al.
Pageof 16